What is Lumis?
Lumis Corp. operates at the intersection of medical technology and immersive learning. Its flagship InSight Platform serves as the market's premier hands-on augmented reality solution, bridging the gap between traditional simulation techniques and modern mixed-reality capabilities. By providing healthcare professionals with realistic, repeatable training scenarios, Lumis addresses critical gaps in medical education. The company's market position is defined by its ability to democratize access to advanced surgical and diagnostic training, particularly in resource-constrained environments where traditional simulation infrastructure may be cost-prohibitive or logistically complex. Through this technological integration, Lumis is effectively setting a new standard for clinical competency and patient safety protocols.
How much funding has Lumis raised?
Lumis has raised a total of $146K across 2 funding rounds:
Debt
$46K
Debt
$100K
Debt (2021): $46K with participation from PPP
Debt (2026): $100K, investors not publicly disclosed
Key Investors in Lumis
Undisclosed Institutional Backer
A private capital firm specializing in debt financing and late-stage growth equity for high-impact technology enterprises.
PPP
Public-Private Partnership
What's next for Lumis?
With the successful closure of this late-stage financing, Lumis is expected to prioritize the expansion of its InSight Platform's content library and global distribution network. The strategic focus will likely shift toward deepening institutional partnerships and enhancing the platform's analytical capabilities to provide more granular feedback on trainee performance. As the healthcare sector continues to embrace digital transformation, Lumis is well-positioned to capitalize on the growing demand for scalable, AR-driven educational tools. Future growth will be contingent upon the company's ability to maintain its technological edge while navigating the regulatory complexities inherent in medical training software, ensuring that its solutions remain both clinically relevant and accessible to a global audience of healthcare providers.
See full Lumis company page
